We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Italian consumer group Codacons has urged public prosecutors to investigate
alleged "cartel" practices in pharmaceutical pricing, claiming that
the local cost of some leading prescription medicines is twice the level in
comparable European Union (EU) states.
Amid Australia's latest round of five-year price negotiations with
the country's Pharmacy Guild, supermarket operator Woolworth's has promised
to deliver savings of up to US$382mn per year in return for favourable market
deregulation.
On May 11, Bushu Pharmaceuticals and Nichiayakuhin Kogyo jointly announced that
they have begun accepting orders for a service that supports CMC (Chemistry,
Manufacturing & Controls) activities conducted by pharmaceutical companies.
Swiss biotech company Speedel Pharma AG said it has pulled its planned initial
public offering (IPO) on the SWX Swiss Exchange due to weak market conditions,
particularly for biotech stocks.
Takeda Pharmaceutical said Wednesday that its group net profit slipped 2.7 percent
for the fiscal year ended March 31, hurt by weaker profits at a U.S. group company.
Chugai Pharmaceutical announced that it has decided to dissolve and liquidate
its Shanghai-based wholly owned subsidiary Shanghai Chugai Pharma by the end
of October.
Codexis and Shasun Chemicals
and Drugs Limited, India, announced the signing of a manufacturing and supply
agreement for a pharmaceutical intermediate for a generic drug.
Israel's 2005 "basket" of drugs to be reimbursed by the
National Health Insurance (NHI) system has highlighted awkward patent discrepancies
on a number of newly included ethical products, reflecting the country's ambiguous
intellectual property regime.